View Prem Premsrirut’s profile on LinkedIn, a professional community of 1 billion members.

Prem Premsrirut is based out of New York, United States, and is the CEO, Executive Director, and Founder of MICOY Therapeutics. Prem attended Stony Brook University.

Dr. Premsrirut was an MD/PhD fellow at SUNY Stony Brook School of Medicine and Cold Spring Harbor Laboratory. She received her Ph.D. in genetics and cancer biology following her training in the …

Dr. Premsrirut is CEO of Mirimus and an expert in the development and use of RNAi transgenic mice. She was an inventor of technological advancements that lead to the development of a high …

Senior Attending Physician and HHMI Investigator, Rockefeller University. Chair of Immunology, St. Jude Children’s Hospital. Chief Data & AI Officer, Pioneering Intelligence, Flagship Pioneering. …

Dr. Premsrirut is CEO of Mirimus and an expert in the development and use of RNAi transgenic mice. She was an inventor of technological advancements that lead to the development of a high …

I’m Prem — a glass-half-full science geek turned entrepreneur. I’ve spent 15+ years leading research teams to combat cancers, genetic diseases and now viral illnesses. Through it all, I’ve tried...

By combining optimized miR30-based shRNA technology with high efficiency ES cell targeting, we developed a flexible and scalable pipeline for the rapid and reliable production of tet-regulated …

Apr 29, 2025 · Dr. Prem Premsrirut is a physician-scientist and biotech innovator leading the charge in RNA-based therapeutics. As Executive Director and CEO of Micoy Therapeutics, she is advancing …

Stay strong 💪 Prem. Nice to see you putting all the Goldman Sach’s 10KSB in action!